Tags: Drug.

Saredutant (SR-48968) is a drug that acts as a NK2 receptor antagonist. It was under development by Sanofi-Aventis as a novel antidepressant and anxiolytic and made it to phase III clinical trials. However in May 2009 Sanofi-Aventis published its quarterly results and announced the cessation of 14 research/development projects among which was saredutant for the treatment of major depressive disorder.

Saredutant.svg
ATC prefix
none
CAS number
142001-63-6
IUPAC name
N-[(2S)-4-(4-acetamido-4-phenylpiperidin-1-yl)- 2-(34-dichlorophenyl)butyl]-N-methylbenzamide
PubChem
104974

Loading...

This page contains content from the copyrighted Wikipedia article "Saredutant"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.